9.3 Complex & Mixed Acid-Base Disorders: Boston vs Copenhagen vs Stewart

ABIM Critical Care Medicine Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Orientation: Format, Blueprint & Study Strategy

1.1 ABIM Critical Care Medicine Exam: Format, Blueprint & Study Strategy

2 Chapter 2: Acute Respiratory Failure & ARDS

2.1 ARDS Definition, Pathophysiology & Phenotypes 2.2 Lung-Protective Mechanical Ventilation 2.3 Refractory ARDS: Prone Positioning, Neuromuscular Blockade & VV-ECMO

3 Chapter 3: Obstructive Airways, Pulmonary Vascular & Pleural Emergencies

3.1 Severe Asthma & COPD Exacerbations in the ICU 3.2 Massive & Submassive Pulmonary Embolism 3.3 Pulmonary Hypertension & Right Ventricular Failure in the ICU 3.4 Massive Hemoptysis, Complex Pleural Effusions & Thoracic Drainage

4 Chapter 4: Airway, Parenchymal & Nonthrombotic Pulmonary Emergencies

4.1 Airway Management, Upper-Airway Obstruction & Artificial-Airway Complications 4.2 Diffuse Alveolar Hemorrhage, Interstitial Lung Disease, Pulmonary Vasculitis & Noncardiogenic Edema 4.3 Severe Community-Acquired & Viral Pneumonia 4.4 Nonthrombotic Embolism (Air, Fat, Amniotic Fluid, Tumor, Septic) & Acute Chest Syndrome

5 Chapter 5: Mechanical Ventilation Modes, Dyssynchrony & Liberation

5.1 Mechanical Ventilator Modes & Advanced Breath Delivery 5.2 Patient-Ventilator Dyssynchrony & Waveform Analysis 5.3 Ventilator Liberation, Spontaneous Breathing Trials & Post-Extubation Support

6 Chapter 6: Shock Syndromes & Hemodynamic Principles

6.1 Shock Classification, Cellular Pathophysiology & Biomarkers 6.2 Hemodynamic Monitoring: Arterial Lines, CVP & Pulmonary Artery Catheter 6.3 Dynamic Assessment of Fluid Responsiveness & Resuscitation Targets

7 Chapter 7: Vasoactive Therapies & Mechanical Circulatory Support

7.1 Vasopressors & Inotropes: Pharmacology & Clinical Titration 7.2 Temporary Mechanical Circulatory Support: IABP, Impella & TandemHeart 7.3 Venoarterial ECMO (VA-ECMO) & Differential Hypoxemia 7.4 Post-Cardiac Arrest Care, Targeted Temperature Management & Neuroprognostication

8 Chapter 8: Acute Kidney Injury & Renal Replacement Therapy

8.1 KDIGO AKI Classification, Etiologies & Diagnostic Evaluation 8.2 Continuous Renal Replacement Therapy (CRRT) vs Intermittent Hemodialysis 8.3 Indications & Timing for RRT in Critical Illness: AKIKI & STARRT-AKI

9 Chapter 9: Electrolyte, Acid-Base & Endocrine Emergencies

9.1 Severe Dysnatremias: Hyponatremia, Hypernatremia & Osmotic Demyelination 9.2 Potassium, Calcium, Magnesium & Phosphate Disorders 9.3 Complex & Mixed Acid-Base Disorders: Boston vs Copenhagen vs Stewart 9.4 Endocrine Crises: DKA, HHS, Thyroid Storm, Myxedema Coma & Adrenal Crisis

10 Chapter 10: Glycemic Control, Hyperammonemia, Pituitary & Adrenal Disorders

10.1 ICU Glycemic Control & Severe Hypoglycemia 10.2 Non-Hepatic Hyperammonemia & Metabolic Encephalopathy 10.3 Pituitary Emergencies, Adrenal Excess & Critical Illness-Related Corticosteroid Insufficiency

11 Chapter 11: Acute Coronary Syndromes & Cardiac Arrhythmias

11.1 Acute Coronary Syndromes & Mechanical Complications of Myocardial Infarction 11.2 Critical Tachyarrhythmias: Atrial Fibrillation with RVR, VT & VF 11.3 Critical Bradyarrhythmias, Conduction Blocks & Temporary Cardiac Pacing

12 Chapter 12: Acute Heart Failure, Valvular & Pericardial Emergencies

12.1 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 12.2 Acute Valvular Regurgitation & Prosthetic Valve Emergencies 12.3 Pericardial Tamponade & Acute Aortic Syndromes

13 Chapter 13: Myocardial Disease, Hypertensive & Cardiac Device Emergencies

13.1 Fulminant Myocarditis, Stress & Peripartum Cardiomyopathy, and Hypertrophic Cardiomyopathy 13.2 Hypertensive Emergencies & Ruptured Abdominal Aortic Aneurysm 13.3 Implanted Cardiac Devices, LVAD Emergencies & Electrical Storm

14 Chapter 14: Sepsis & Systemic Infectious Diseases

14.1 Sepsis-3 Definitions & Surviving Sepsis Campaign 2026 Guidelines 14.2 Refractory Septic Shock & Adjunctive Therapies 14.3 Multidrug-Resistant Pathogens & Antimicrobial Stewardship in the ICU

15 Chapter 15: ICU-Acquired & Severe Focal Infections

15.1 Hospital-Acquired & Ventilator-Associated Pneumonia 15.2 Central Line-Associated Bloodstream Infections & Catheter-Associated UTIs 15.3 Intra-Abdominal Sepsis, Necrotizing Soft Tissue Infections & CNS Infections

16 Chapter 16: Focal, Special-Host & Systemic Infections

16.1 CNS Infections Beyond Bacterial Meningitis: Encephalitis, Brain Abscess & Epidural Abscess 16.2 Infections in the Immunocompromised Host, Tropical & Bioterror Infections 16.3 Infective Endocarditis, Device Infections & Other Focal Cardiovascular Infections 16.4 Antimicrobial Pharmacokinetics, Allergy, Toxicity & Infection Prevention 16.5 Gastrointestinal & Hepatobiliary Infections: Fulminant C. difficile, Typhlitis, CMV Colitis & Abscesses

17 Chapter 17: Neurocritical Care & Coma

17.1 Coma, Altered Mental Status & Acute Delirium in the ICU 17.2 Status Epilepticus & Non-Convulsive Status Epilepticus 17.3 Acute Ischemic Stroke & Intracranial Hemorrhage

18 Chapter 18: Cerebrovascular Syndromes, Encephalopathy & Withdrawal States

18.1 Cerebral Venous Sinus Thrombosis, PRES & Reversible Cerebral Vasoconstriction Syndrome 18.2 Alcohol & Sedative Withdrawal, Wernicke Encephalopathy & Drug-Induced Encephalopathy

19 Chapter 19: Intracranial Hypertension & Neuromuscular Weakness

19.1 Intracranial Pressure Monitoring, Cerebral Perfusion & Tiered ICP Management 19.2 Acute Neuromuscular Respiratory Failure, ICU-Acquired Weakness & Brain Death Determination

20 Chapter 20: Traumatic Brain Injury, Spinal Cord Injury & Toxin-Mediated Paralysis

20.1 Traumatic Brain Injury Management & Paroxysmal Sympathetic Hyperactivity 20.2 Acute Spinal Cord Injury, Neurogenic Shock & Autonomic Dysreflexia 20.3 Toxin-Mediated Paralysis & Neuromuscular Crises: Botulism, Tetanus, Tick Paralysis & Myasthenic Crisis

21 Chapter 21: Gastrointestinal, Hepatic & Abdominal Emergencies

21.1 Acute Upper & Lower Gastrointestinal Bleeding in the ICU 21.2 Acute Liver Failure & Severe Acute Pancreatitis 21.3 Abdominal Compartment Syndrome & Acute Mesenteric Ischemia

22 Chapter 22: Luminal GI Emergencies & Complications of Cirrhosis

22.1 Esophageal, Gastric & Bowel Emergencies: Perforation, Obstruction, Ogilvie Syndrome & Colonic Ischemia 22.2 Complications of Cirrhosis: Alcohol-Associated Hepatitis, Hepatorenal Syndrome & Pulmonary Vascular Syndromes

23 Chapter 23: Trauma, Burns & Perioperative Critical Care

23.1 Polytrauma Resuscitation, Damage Control & Massive Transfusion 23.2 Severe Burn Injury, Inhalation Injury & Environmental Emergencies 23.3 Perioperative Critical Care for High-Risk Surgical Patients

24 Chapter 24: Thoracic Trauma, Environmental Injury & Obstetric Critical Care

24.1 Thoracic Trauma: Flail Chest, Pulmonary Contusion, Great Vessel & Tracheobronchial Injury 24.2 Environmental Injury: Drowning, Diving, Altitude, Heat, Cold, Electrical & Radiation 24.3 Obstetric & Genitourinary Emergencies and the Physiology of Pregnancy

25 Chapter 25: Transplantation, Donor Management & Post-Cardiac Surgery Care

25.1 Solid Organ Transplant Recipients & Deceased Donor Management 25.2 Post-Cardiac Surgery Critical Care: Bleeding, Tamponade, Low Output & Vasoplegia

26 Chapter 26: Hematologic Emergencies, Toxicology, Critical Ultrasound & ICU Liberation

26.1 Hematologic Emergencies in the ICU: HIT, DIC, TMA & Anticoagulant Reversal 26.2 Critical Care Toxicology, Toxidromes & Specific Antidotes 26.3 Critical Care Point-of-Care Ultrasound (POCUS) 26.4 ICU Liberation, Analgosedation, Goals of Care & Critical Care Ethics

27 Chapter 27: Transfusion Medicine, Hematologic & Oncologic Disorders

27.1 Transfusion Medicine: Products, Thresholds, Reactions & Apheresis 27.2 Red and White Cell Disorders, Hemoglobinopathies, Factor Deficiencies & Hypercoagulable States 27.3 Oncologic Emergencies, Hematopoietic Cell Transplant Complications & Cellular Therapy Toxicity

28 Chapter 28: Clinical Pharmacology, Adverse Drug Reactions & Specific Poisonings

28.1 Pharmacokinetic Principles, Dose Adjustment & Drug Interactions in Critical Illness 28.2 Adverse Drug Reactions: Anaphylaxis, Severe Cutaneous Reactions & Hyperthermic Syndromes 28.3 Specific Poisonings: Sodium-Channel Blockers, Lithium, Valproate, Theophylline, Iron, Sulfonylureas & Methemoglobinemia

29 Chapter 29: Ethics, Research Methods, Administration & Abdominal Ultrasound

29.1 Advance Care Planning, Nonbeneficial Treatment, Informed Consent & Confidentiality 29.2 Critical Care Research Methods, Statistics, IRB Oversight & Quality Improvement 29.3 Abdominal, Vascular & Procedural Point-of-Care Ultrasound

9.3 Complex & Mixed Acid-Base Disorders: Boston vs Copenhagen vs Stewart

Key Takeaways Explain This Topic AI

Systematic arterial blood gas interpretation integrates primary acid-base disturbances, expected secondary physiological compensation (Winter's formula for metabolic acidosis: PaCO 2 = 1.5 × [ HCO 3 − ] + 8 ± 2 \text{PaCO}_2 = 1.5 \times [\text{HCO}_3^-] + 8 \pm 2 PaCO 2 ​ = 1.5 × [ HCO 3 − ​ ] + 8 ± 2 ), and albumin-corrected serum anion gap ( Observed AG + 2.5 × [ 4.0 − Albumin ] \text{Observed AG} + 2.5 \times [4.0 - \text{Albumin}] Observed AG + 2.5 × [ 4.0 − Albumin ] ).

The Delta-Delta ratio ( Δ AG / Δ [ HCO 3 − ] \Delta\text{AG}/\Delta[\text{HCO}_3^-] Δ AG /Δ [ HCO 3 − ​ ] ) exposes occult mixed disorders: a ratio < 0.4 − 0.8 < 0.4-0.8 < 0.4 − 0.8 unmasks a concurrent normal anion gap acidosis (NAGMA), while a ratio > 1.6 − 2.0 > 1.6-2.0 > 1.6 − 2.0 identifies a concurrent metabolic alkalosis or pre-existing respiratory acidosis.

The Urine Anion Gap ( UNa + UK − UCl \text{UNa} + \text{UK} - \text{UCl} UNa + UK − UCl ) differentiates NAGMA etiologies: negative values confirm intact renal ammonium excretion in gastrointestinal bicarbonate loss, while positive values indicate defective distal tubular acidification (Type 1 RTA).

The Stewart physicochemical framework defines acid-base status through three independent variables: PaCO 2 \text{PaCO}_2 PaCO 2 ​ , Strong Ion Difference (SID), and total weak non-volatile acids ( A tot A_{\text{tot}} A tot ​ ); infusing large volumes of 0.9% normal saline reduces plasma SID, directly causing hyperchloremic metabolic acidosis.

Balanced crystalloids (Lactated Ringer's, Plasma-Lyte) preserve plasma strong ion difference and avoid hyperchloremic acidosis; SMART showed a modest reduction in major adverse kidney events (14.3% vs. 15.4%), while BaSICS and PLUS found no difference in mortality.

Last updated: October 2026

Systematic Arterial Blood Gas (ABG) Interpretation

Acid-base derangements in the ICU are rarely isolated, monolithic events. Critically ill patients frequently harbor two or three concurrent acid-base processes simultaneously (e.g., septic shock with lactic acidosis, hypoventilatory respiratory failure, and contraction alkalosis from nasogastric suctioning). Systematic ABG analysis must follow an unvarying, sequential five-step algorithm:

Loading diagram...

Step-by-Step Diagnostic Framework

Step 1: Evaluate Arterial pH :

• Normal pH: 7.35 to 7.45 7.35\text{ to }7.45 7.35 to 7.45 ;
• Acidemia: pH < 7.35 \text{pH} < 7.35 pH < 7.35 ;
• Alkalemia: pH > 7.45 \text{pH} > 7.45 pH > 7.45 ;

Note : A normal pH does not establish normal acid-base physiology; it frequently signifies a severe mixed disorder (e.g., severe HAGMA balanced by severe primary metabolic or respiratory alkalosis).

Step 2: Identify the Primary Disturbance :

Look at PaCO 2 \text{PaCO}_2 PaCO 2 ​ (normal 35 − 45 mmHg 35-45\text{ mmHg} 35 − 45 mmHg ) and [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] (normal 22 − 26 mEq/L 22-26\text{ mEq/L} 22 − 26 mEq/L );

If pH is acidemic ( < 7.35 < 7.35 < 7.35 ): primary metabolic acidosis if [ HCO 3 − ] < 22 mEq/L [\text{HCO}_3^-] < 22\text{ mEq/L} [ HCO 3 − ​ ] < 22 mEq/L ; primary respiratory acidosis if PaCO 2 > 45 mmHg \text{PaCO}_2 > 45\text{ mmHg} PaCO 2 ​ > 45 mmHg ;

If pH is alkalemic ( > 7.45 > 7.45 > 7.45 ): primary metabolic alkalosis if [ HCO 3 − ] > 26 mEq/L [\text{HCO}_3^-] > 26\text{ mEq/L} [ HCO 3 − ​ ] > 26 mEq/L ; primary respiratory alkalosis if PaCO 2 < 35 mmHg \text{PaCO}_2 < 35\text{ mmHg} PaCO 2 ​ < 35 mmHg .

Step 3: Calculate Expected Physiological Compensation (The Boston Rules) :

Physiological compensation never fully normalizes arterial pH. If measured compensation deviates from predicted values, a secondary independent acid-base disorder is confirmed:

Metabolic Acidosis (Winter's Formula) : Expected PaCO 2 = 1.5 × [ HCO 3 − ] + 8 ± 2 \text{Expected } \text{PaCO}_2 = 1.5 \times [\text{HCO}_3^-] + 8 \pm 2 Expected PaCO 2 ​ = 1.5 × [ HCO 3 − ​ ] + 8 ± 2

If measured PaCO 2 > expected \text{PaCO}_2 > \text{expected} PaCO 2 ​ > expected : concurrent respiratory acidosis (respiratory muscle exhaustion, hypoventilation, CNS depression);

If measured PaCO 2 < expected \text{PaCO}_2 < \text{expected} PaCO 2 ​ < expected : concurrent respiratory alkalosis (pain, sepsis, early salicylate toxicity, hepatic encephalopathy).

Metabolic Alkalosis : Expected PaCO 2 = 40 + 0.7 × ( [ HCO 3 − ] − 24 ) ± 5 ( or Δ PaCO 2 = 0.7 × Δ [ HCO 3 − ] ) \text{Expected } \text{PaCO}_2 = 40 + 0.7 \times ([\text{HCO}_3^-] - 24) \pm 5 \quad (\text{or } \Delta\text{PaCO}_2 = 0.7 \times \Delta[\text{HCO}_3^-]) Expected PaCO 2 ​ = 40 + 0.7 × ([ HCO 3 − ​ ] − 24 ) ± 5 ( or Δ PaCO 2 ​ = 0.7 × Δ [ HCO 3 − ​ ])

The respiratory center compensates by hypoventilating, but physiological hypoxemic drive rarely permits PaCO 2 \text{PaCO}_2 PaCO 2 ​ to rise above 55 to 60 mmHg 55\text{ to }60\text{ mmHg} 55 to 60 mmHg in spontaneous breathing.

Respiratory Acidosis :

Acute ( < 24 hours < 24\text{ hours} < 24 hours , cellular buffering only): For every 10 mmHg 10\text{ mmHg} 10 mmHg rise in PaCO 2 \text{PaCO}_2 PaCO 2 ​ , [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] increases by 1 mEq/L 1\text{ mEq/L} 1 mEq/L ( pH \text{pH} pH falls ≈ 0.08 \approx 0.08 ≈ 0.08 );

Chronic ( > 48 − 72 hours > 48-72\text{ hours} > 48 − 72 hours , renal compensation via H + \text{H}^+ H + secretion): For every 10 mmHg 10\text{ mmHg} 10 mmHg rise in PaCO 2 \text{PaCO}_2 PaCO 2 ​ , [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] increases by 3.5 to 4.0 mEq/L 3.5\text{ to }4.0\text{ mEq/L} 3.5 to 4.0 mEq/L ( pH \text{pH} pH falls ≈ 0.03 \approx 0.03 ≈ 0.03 ).

Respiratory Alkalosis :

Acute : For every 10 mmHg 10\text{ mmHg} 10 mmHg decrease in PaCO 2 \text{PaCO}_2 PaCO 2 ​ , [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] decreases by 2 mEq/L 2\text{ mEq/L} 2 mEq/L ( pH \text{pH} pH rises ≈ 0.08 \approx 0.08 ≈ 0.08 );

Chronic : For every 10 mmHg 10\text{ mmHg} 10 mmHg decrease in PaCO 2 \text{PaCO}_2 PaCO 2 ​ , [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] decreases by 4 to 5 mEq/L 4\text{ to }5\text{ mEq/L} 4 to 5 mEq/L ( pH \text{pH} pH rises ≈ 0.03 \approx 0.03 ≈ 0.03 ).

The Serum Anion Gap and Albumin Correction

The serum anion gap represents the concentration of unmeasured anions in plasma relative to unmeasured cations, derived from the law of electroneutrality:

Anion Gap (AG) = [ Na + ] − ( [ Cl − ] + [ HCO 3 − ] ) \text{Anion Gap (AG)} = [\text{Na}^+] - ([\text{Cl}^-] + [\text{HCO}_3^-]) Anion Gap (AG) = [ Na + ] − ([ Cl − ] + [ HCO 3 − ​ ])

Normal reference range: 10 to 12 mEq/L 10\text{ to }12\text{ mEq/L} 10 to 12 mEq/L (or 8 − 12 mEq/L 8-12\text{ mEq/L} 8 − 12 mEq/L ). Some centers include potassium ( [ Na + + K + ] − [ Cl − + HCO 3 − ] [\text{Na}^+ + \text{K}^+] - [\text{Cl}^- + \text{HCO}_3^-] [ Na + + K + ] − [ Cl − + HCO 3 − ​ ] ), shifting normal to 12 − 16 mEq/L 12-16\text{ mEq/L} 12 − 16 mEq/L ; standard critical care practice omits potassium.

Mandatory Albumin Correction

Circulating serum albumin accounts for approximately 75 % 75\% 75% to 80 % 80\% 80% of the normal unmeasured anion pool. Each albumin molecule carries approximately 19 negative charges at physiological pH ( 7.40 7.40 7.40 ). Consequently, in hypoalbuminemia (ubiquitous in sepsis, cirrhosis, malnutrition, and nephrotic syndrome), the "baseline" normal anion gap is markedly depressed.

Warning

For every 1.0 g/dL 1.0\text{ g/dL} 1.0 g/dL reduction in serum albumin below 4.0 g/dL 4.0\text{ g/dL} 4.0 g/dL , the baseline normal anion gap decreases by 2.5 mEq/L 2.5\text{ mEq/L} 2.5 mEq/L : Corrected AG = Observed AG + 2.5 × ( 4.0 − Albumin [g/dL] ) \text{Corrected AG} = \text{Observed AG} + 2.5 \times (4.0 - \text{Albumin [g/dL]}) Corrected AG = Observed AG + 2.5 × ( 4.0 − Albumin [g/dL] ) Failure to calculate corrected AG in a critically ill patient with an albumin of 1.5 g/dL 1.5\text{ g/dL} 1.5 g/dL will fail to diagnose high anion gap metabolic acidosis in up to 40% of cases.

High Anion Gap Metabolic Acidosis: The GOLD MARK Framework

When corrected AG exceeds 12 mEq/L 12\text{ mEq/L} 12 mEq/L , a High Anion Gap Metabolic Acidosis (HAGMA) is present. The contemporary, subspecialty-standard mnemonic GOLD MARK covers modern ICU etiologies:

Loading diagram...

G — Glycols :

Ethylene glycol (antifreeze): metabolized by alcohol dehydrogenase to glycolic and oxalic acid; causes acute tubular necrosis with calcium oxalate envelope-shaped crystalluria and acute renal failure.

Propylene glycol : vehicle for IV medications (lorazepam, diazepam, esmolol, nitroglycerin, phenobarbital); causes high osmolal gap HAGMA with proximal renal tubular injury.

O — Oxoproline (5-Oxoproline / Pyroglutamic Acid) : Occurs in critically ill, septic, malnourished females receiving chronic therapeutic doses of acetaminophen (paracetamol) . Glutathione depletion uncouples the gamma-glutamyl cycle, shunting gamma-glutamylcysteine into 5-oxoproline, causing profound unexplained HAGMA without an elevated osmolal gap.

L — L-Lactate : Normal < 2.0 mmol/L < 2.0\text{ mmol/L} < 2.0 mmol/L ; severe lactic acidosis > 4.0 mmol/L > 4.0\text{ mmol/L} > 4.0 mmol/L . Partitioned into:

Type A : Tissue hypoperfusion and anaerobic metabolism (septic shock, cardiogenic shock, hemorrhagic shock, mesenteric ischemia, severe hypoxemia).

Type B : Impaired cellular clearance or mitochondrial poisoning without overt macro-hypoperfusion (liver failure, metformin toxicity, malignancies [Warburg effect], thiamine deficiency [pyruvate dehydrogenase failure], nucleoside reverse transcriptase inhibitors [NRTIs]).

D — D-Lactate : Produced by colonic lactobacilli fermenting unabsorbed carbohydrates in patients with short bowel syndrome or extensive small bowel resection. Standard laboratory assays measure only L-lactate; D-lactic acidosis presents with profound encephalopathy, ataxia, confusion, and unexplained HAGMA with a "normal" reported L-lactate.

M — Methanol : Found in windshield wiper fluids; metabolized to formaldehyde and formic acid , causing optic papillitis, retinal edema, "snowstorm" visual loss, and bilateral putaminal necrosis.

A — Aspirin (Salicylates) : Uncouples oxidative phosphorylation and directly stimulates the medullary respiratory center. Classically produces a mixed Primary Respiratory Alkalosis and High Anion Gap Metabolic Acidosis .

R — Renal Failure (Uremia) : In KDIGO Stage 3 AKI or advanced CKD, impaired glomerular filtration fails to excrete unmeasured organic and inorganic acid anions (sulfates, phosphates, urate, hippurate).

K — Ketoacidosis : Accumulation of acetoacetate and beta-hydroxybutyrate :

Diabetic Ketoacidosis (DKA) ;

Alcoholic Ketoacidosis (AKA) : Occurs in chronic alcoholics after a binge followed by protracted vomiting, starvation, and sudden alcohol cessation; characterized by marked ketonemia with low/normal blood glucose;

Starvation Ketoacidosis (SKA) : Mild ketoacidosis ( [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] rarely < 18 mEq/L < 18\text{ mEq/L} < 18 mEq/L ) from prolonged carbohydrate deprivation.

The Delta-Delta ( Δ AG / Δ [ HCO 3 − ] \Delta\text{AG} / \Delta[\text{HCO}_3^-] Δ AG /Δ [ HCO 3 − ​ ] ) and Delta Gap Analysis

In pure, uncomplicated HAGMA, every milliequivalent of unmeasured acid anion added to the circulation titrates and consumes exactly one milliequivalent of bicarbonate buffer ( 1 : 1 1:1 1 : 1 stoichiometric titration). Therefore, the increase in anion gap above normal ( Δ AG \Delta\text{AG} Δ AG ) should equal the decrease in serum bicarbonate below normal ( Δ [ HCO 3 − ] \Delta[\text{HCO}_3^-] Δ [ HCO 3 − ​ ] ).

Mathematical Formulation

Δ AG = Observed AG − 12 \Delta\text{AG} = \text{Observed AG} - 12 Δ AG = Observed AG − 12 Δ [ HCO 3 − ] = 24 − Observed [ HCO 3 − ] \Delta[\text{HCO}_3^-] = 24 - \text{Observed }[\text{HCO}_3^-] Δ [ HCO 3 − ​ ] = 24 − Observed [ HCO 3 − ​ ] Delta-Delta Ratio = Δ AG Δ [ HCO 3 − ] = Observed AG − 12 24 − [ HCO 3 − ] \text{Delta-Delta Ratio} = \frac{\Delta\text{AG}}{\Delta[\text{HCO}_3^-]} = \frac{\text{Observed AG} - 12}{24 - [\text{HCO}_3^-]} Delta-Delta Ratio = Δ [ HCO 3 − ​ ] Δ AG ​ = 24 − [ HCO 3 − ​ ] Observed AG − 12 ​

Loading diagram...

Clinical Interpretation

Ratio < 0.4 to 0.8 < 0.4\text{ to }0.8 < 0.4 to 0.8 (Mixed HAGMA and NAGMA) :

Bicarbonate has dropped much further than can be accounted for by the addition of unmeasured anions. This proves the coexistence of a Normal Anion Gap (Hyperchloremic) Metabolic Acidosis (e.g., patient with diabetic ketoacidosis who also has severe secretory diarrhea, or septic shock resuscitated with large volumes of 0.9 % 0.9\% 0.9% normal saline).

Ratio 1.0 to 1.6 1.0\text{ to }1.6 1.0 to 1.6 (Pure HAGMA) :

Uncomplicated single disturbance; unmeasured anions account entirely for bicarbonate depletion.

Ratio > 1.6 to 2.0 > 1.6\text{ to }2.0 > 1.6 to 2.0 (Mixed HAGMA and Metabolic Alkalosis) :

Bicarbonate is significantly higher than expected for the degree of anion gap elevation. This establishes a concurrent metabolic alkalosis (e.g., patient with lactic acidosis from mesenteric ischemia who is actively vomiting or receiving nasogastric suction) or pre-existing chronic compensated respiratory acidosis (elevated baseline baseline bicarbonate in severe COPD).

Normal Anion Gap Metabolic Acidosis (NAGMA) and the Urine Anion Gap

NAGMA (hyperchloremic metabolic acidosis) occurs when serum bicarbonate is lost and replaced milliequivalent-for-milliequivalent by serum chloride, maintaining electroneutrality and preserving an anion gap between 10 and 12 mEq/L 10\text{ and }12\text{ mEq/L} 10 and 12 mEq/L .

Etiologic Partitioning: GI vs. Renal Loss

Gastrointestinal Bicarbonate Loss : Severe watery diarrhea, enterocutaneous fistulae, biliary/pancreatic drainage, surgical ureterosigmoidostomy;

Renal Tubular Acidosis (RTA) : Inability of the nephron to excrete net acid or reabsorb filtered bicarbonate;

Exogenous Chloride Loading : Rapid infusion of large volumes of 0.9 % 0.9\% 0.9% normal saline.

The Urine Anion Gap (UAG)

When the cause of NAGMA is not clinically obvious, calculating the Urine Anion Gap differentiates gastrointestinal bicarbonate loss from renal tubular dysfunction:

Urine Anion Gap (UAG) = [ U Na ] + [ U K ] − [ U Cl ] \text{Urine Anion Gap (UAG)} = [\text{U}_{\text{Na}}] + [\text{U}_{\text{K}}] - [\text{U}_{\text{Cl}}] Urine Anion Gap (UAG) = [ U Na ​ ] + [ U K ​ ] − [ U Cl ​ ]

Loading diagram...

Physiological Basis : In metabolic acidosis, healthy kidneys dramatically upregulate ammonium ( NH 4 + \text{NH}_4^+ NH 4 + ​ ) excretion (up to 200 − 300 mEq/day 200-300\text{ mEq/day} 200 − 300 mEq/day ). Ammonium is excreted primarily paired with chloride ( NH 4 + Cl − \text{NH}_4^+\text{Cl}^- NH 4 + ​ Cl − ). Because NH 4 + \text{NH}_4^+ NH 4 + ​ is an unmeasured cation, high urinary ammonium forces urinary chloride ( [ U Cl ] [\text{U}_{\text{Cl}}] [ U Cl ​ ] ) to rise substantially above the sum of [ U Na ] [\text{U}_{\text{Na}}] [ U Na ​ ] and [ U K ] [\text{U}_{\text{K}}] [ U K ​ ] .

Negative UAG (typically − 20 to − 50 mEq/L -20\text{ to } -50\text{ mEq/L} − 20 to − 50 mEq/L ) : Reflects robust renal ammoniagenesis and excretion of unmeasured NH 4 + \text{NH}_4^+ NH 4 + ​ . Confirms intact renal response to GI bicarbonate loss (diarrhea).

Positive UAG (typically + 20 to + 50 mEq/L +20\text{ to } +50\text{ mEq/L} + 20 to + 50 mEq/L ) : Demonstrates failure of renal NH 4 + \text{NH}_4^+ NH 4 + ​ excretion despite severe systemic acidemia. Confirms Distal Renal Tubular Acidosis (Type 1 RTA) or Type 4 RTA (hypoaldosteronism) .

The Stewart Physicochemical Approach: Strong Ion Difference (SID)

Traditional acid-base frameworks (the Boston and Copenhagen schools) view bicarbonate and hydrogen ions as primary drivers of acid-base balance. In 1983, Peter Stewart introduced a quantitative, physicochemical framework based on fundamental physical laws of solutions: electroneutrality , conservation of mass , and dissociation equilibria of weak electrolytes .

The Three Independent Variables

Under Stewart's principles, pH and [ HCO 3 − ] [\text{HCO}_3^-] [ HCO 3 − ​ ] are dependent variables that change instantaneously and passively in response to alterations in three strictly independent variables :

Arterial PaCO 2 \text{PaCO}_2 PaCO 2 ​ : The volatile, respiratory independent variable controlled by alveolar ventilation;

Strong Ion Difference (SID) : The electrical charge difference between fully dissociated strong cations and strong anions in plasma;

Total Non-Volatile Weak Acids ( A tot A_{\text{tot}} A tot ​ ) : The total concentration of non-dissociated and dissociated weak acids, consisting almost entirely of serum albumin and inorganic phosphate .

Apparent Strong Ion Difference (SIDa)

Strong ions are completely dissociated at physiological pH. SID represents the net positive charge of these ions:

SIDa = ( [ Na + ] + [ K + ] + [ Ca 2 + ] + [ Mg 2 + ] ) − ( [ Cl − ] + [ Lactate − ] ) \text{SIDa} = ([\text{Na}^+] + [\text{K}^+] + [\text{Ca}^{2+}] + [\text{Mg}^{2+}]) - ([\text{Cl}^-] + [\text{Lactate}^-]) SIDa = ([ Na + ] + [ K + ] + [ Ca 2 + ] + [ Mg 2 + ]) − ([ Cl − ] + [ Lactate − ])

In simplified clinical bedside practice, SID is approximated using the predominant strong ions: Simplified SID ≈ [ Na + ] − [ Cl − ] \text{Simplified SID} \approx [\text{Na}^+] - [\text{Cl}^-] Simplified SID ≈ [ Na + ] − [ Cl − ]

Normal Plasma SID : 38 to 42 mEq/L 38\text{ to }42\text{ mEq/L} 38 to 42 mEq/L (typically ≈ 40 mEq/L \approx 40\text{ mEq/L} ≈ 40 mEq/L );

Strong Ion Acidosis : A reduction in SID ( < 38 mEq/L < 38\text{ mEq/L} < 38 mEq/L ) forces water molecules to dissociate into H + \text{H}^+ H + and OH − \text{OH}^- OH − to satisfy electroneutrality, increasing [ H + ] [\text{H}^+] [ H + ] and driving metabolic acidosis . The quintessential cause is hyperchloremia;

Strong Ion Alkalosis : An elevation in SID ( > 42 mEq/L > 42\text{ mEq/L} > 42 mEq/L ) decreases [ H + ] [\text{H}^+] [ H + ] , driving metabolic alkalosis . The quintessential cause is hypochloremia (vomiting, loop diuretics).

The Physicochemical Mechanism of 0.9% Normal Saline Acidosis

Stewart physiology provides the definitive thermodynamic explanation for "dilutional / normal saline acidosis":

Normal plasma has a sodium of 140 mEq/L 140\text{ mEq/L} 140 mEq/L and chloride of 100 mEq/L 100\text{ mEq/L} 100 mEq/L , yielding a baseline SID of 40 mEq/L 40\text{ mEq/L} 40 mEq/L .

Unbalanced crystalloid ( 0.9 % 0.9\% 0.9% Normal Saline) contains 154 mEq/L 154\text{ mEq/L} 154 mEq/L of Na + \text{Na}^+ Na + and 154 mEq/L 154\text{ mEq/L} 154 mEq/L of Cl − \text{Cl}^- Cl − . Its Strong Ion Difference is 0 mEq/L 0\text{ mEq/L} 0 mEq/L ( 154 − 154 = 0 154 - 154 = 0 154 − 154 = 0 ).

When large volumes of normal saline are infused into a patient, the addition of a solution with SID = 0 \text{SID} = 0 SID = 0 dilutes plasma SID toward zero (lowering plasma SID from 40 mEq/L 40\text{ mEq/L} 40 mEq/L down to 30 − 32 mEq/L 30-32\text{ mEq/L} 30 − 32 mEq/L ). By thermodynamic necessity, this drop in SID drives auto-ionization of water, producing hyperchloremic metabolic acidosis .

Furthermore, high tubular chloride delivery to the macula densa triggers tubuloglomerular feedback, inducing renal afferent arteriolar vasoconstriction, dropping renal cortical perfusion, and predisposing to acute kidney injury .

Balanced Crystalloids (Lactated Ringer's, Plasma-Lyte) : Contain physiological chloride concentrations ( 98 − 109 mEq/L 98-109\text{ mEq/L} 98 − 109 mEq/L ) and contain metabolizable organic anions (lactate, acetate, or gluconate) that are rapidly consumed by the liver and muscle. Their effective SID mirrors plasma ( 28 − 50 mEq/L 28-50\text{ mEq/L} 28 − 50 mEq/L ), preserving plasma SID and largely avoiding hyperchloremic acidosis. Clinically, SMART (2018) found a small reduction in the composite of death, new RRT, or persistent kidney dysfunction, but the larger BaSICS (2021) and PLUS (2022) trials found no mortality difference; the 2026 Surviving Sepsis Campaign still suggests balanced crystalloids over 0.9% saline for sepsis. Hypotonic balanced fluids such as lactated Ringer solution are often avoided in traumatic brain injury, based on trial subgroup data rather than the sepsis guideline.

Step-by-Step Acid-Base Algorithm and Worked Cases

Case Parameter Case 1: Salicylate Poisoning Case 2: DKA with Protracted Emesis Case 3: Sepsis in Cirrhosis / Hypoalbuminemia Case 4: Post-Surgical Severe Diarrhea

Arterial Blood Gas pH 7.46 , PaCO 2 20 , HCO 3 14 \text{pH } 7.46, \text{PaCO}_2\ 20, \text{HCO}_3\ 14 pH 7.46 , PaCO 2 ​ 20 , HCO 3 ​ 14 pH 7.38 , PaCO 2 38 , HCO 3 22 \text{pH } 7.38, \text{PaCO}_2\ 38, \text{HCO}_3\ 22 pH 7.38 , PaCO 2 ​ 38 , HCO 3 ​ 22 pH 7.32 , PaCO 2 30 , HCO 3 15 \text{pH } 7.32, \text{PaCO}_2\ 30, \text{HCO}_3\ 15 pH 7.32 , PaCO 2 ​ 30 , HCO 3 ​ 15 pH 7.22 , PaCO 2 28 , HCO 3 11 \text{pH } 7.22, \text{PaCO}_2\ 28, \text{HCO}_3\ 11 pH 7.22 , PaCO 2 ​ 28 , HCO 3 ​ 11

Serum Electrolytes Na 140 , Cl 102 , Albumin 4.0 \text{Na } 140, \text{Cl } 102, \text{Albumin } 4.0 Na 140 , Cl 102 , Albumin 4.0 Na 142 , Cl 86 , Albumin 4.0 \text{Na } 142, \text{Cl } 86, \text{Albumin } 4.0 Na 142 , Cl 86 , Albumin 4.0 Na 134 , Cl 105 , Albumin 1.6 \text{Na } 134, \text{Cl } 105, \text{Albumin } 1.6 Na 134 , Cl 105 , Albumin 1.6 Na 138 , Cl 115 , Albumin 4.0 \text{Na } 138, \text{Cl } 115, \text{Albumin } 4.0 Na 138 , Cl 115 , Albumin 4.0

Urine Electrolytes N/A N/A N/A U Na 30 , U K 20 , U Cl 85 \text{U}_{\text{Na}}\ 30, \text{U}_{\text{K}}\ 20, \text{U}_{\text{Cl}}\ 85 U Na ​ 30 , U K ​ 20 , U Cl ​ 85

Primary Disturbance Primary Respiratory Alkalemia ( pH > 7.45 , PaCO 2 < 35 \text{pH } > 7.45, \text{PaCO}_2 < 35 pH > 7.45 , PaCO 2 ​ < 35 ) Near-normal pH with profound underlying derangements Primary Acidemia with Metabolic Acidosis ( HCO 3 < 22 \text{HCO}_3 < 22 HCO 3 ​ < 22 ) Primary Acidemia with Metabolic Acidosis ( HCO 3 < 22 \text{HCO}_3 < 22 HCO 3 ​ < 22 )

Winter's Formula Check N/A (Primary process is respiratory) Expected PaCO 2 = 1.5 ( 22 ) + 8 = 41 ± 2 \text{PaCO}_2 = 1.5(22)+8 = 41 \pm 2 PaCO 2 ​ = 1.5 ( 22 ) + 8 = 41 ± 2 (39 to 43). Actual PaCO 2 = 38 \text{PaCO}_2 = 38 PaCO 2 ​ = 38 (just below range: borderline, at most a minimal added respiratory alkalosis) Expected PaCO 2 = 1.5 ( 15 ) + 8 = 30.5 ± 2 \text{PaCO}_2 = 1.5(15)+8 = 30.5 \pm 2 PaCO 2 ​ = 1.5 ( 15 ) + 8 = 30.5 ± 2 . Actual PaCO 2 = 30 \text{PaCO}_2 = 30 PaCO 2 ​ = 30 (appropriate) Expected PaCO 2 = 1.5 ( 11 ) + 8 = 24.5 ± 2 \text{PaCO}_2 = 1.5(11)+8 = 24.5 \pm 2 PaCO 2 ​ = 1.5 ( 11 ) + 8 = 24.5 ± 2 . Actual PaCO 2 = 28 \text{PaCO}_2 = 28 PaCO 2 ​ = 28 (concurrent resp acidosis)

Anion Gap Calculation AG = 140 − ( 102 + 14 ) = 24 \text{AG} = 140 - (102 + 14) = 24 AG = 140 − ( 102 + 14 ) = 24 (Elevated) AG = 142 − ( 86 + 22 ) = 34 \text{AG} = 142 - (86 + 22) = 34 AG = 142 − ( 86 + 22 ) = 34 (Markedly Elevated) Observed AG = 134 − ( 105 + 15 ) = 14 \text{AG} = 134 - (105 + 15) = 14 AG = 134 − ( 105 + 15 ) = 14 . Corrected AG = 14 + 2.5 ( 4.0 − 1.6 ) = 20 \text{AG} = 14 + 2.5(4.0 - 1.6) = 20 AG = 14 + 2.5 ( 4.0 − 1.6 ) = 20 (Elevated) AG = 138 − ( 115 + 11 ) = 12 \text{AG} = 138 - (115 + 11) = 12 AG = 138 − ( 115 + 11 ) = 12 (Normal Anion Gap)

Delta-Delta Analysis Δ AG = 24 − 12 = 12 \Delta\text{AG} = 24 - 12 = 12 Δ AG = 24 − 12 = 12 . Δ HCO 3 = 24 − 14 = 10 \Delta\text{HCO}_3 = 24 - 14 = 10 Δ HCO 3 ​ = 24 − 14 = 10 . Ratio = 1.2 = 1.2 = 1.2 (Pure HAGMA) Δ AG = 34 − 12 = 22 \Delta\text{AG} = 34 - 12 = 22 Δ AG = 34 − 12 = 22 . Δ HCO 3 = 24 − 22 = 2 \Delta\text{HCO}_3 = 24 - 22 = 2 Δ HCO 3 ​ = 24 − 22 = 2 . Ratio = 22 / 2 = 11.0 = 22/2 = 11.0 = 22/2 = 11.0 ( > 2.0 > 2.0 > 2.0 ) Δ AG = 20 − 12 = 8 \Delta\text{AG} = 20 - 12 = 8 Δ AG = 20 − 12 = 8 . Δ HCO 3 = 24 − 15 = 9 \Delta\text{HCO}_3 = 24 - 15 = 9 Δ HCO 3 ​ = 24 − 15 = 9 . Ratio = 8 / 9 = 0.89 = 8/9 = 0.89 = 8/9 = 0.89 N/A (Pure NAGMA). Urine AG = 30 + 20 − 85 = − 35 mEq/L = 30 + 20 - 85 = -35\text{ mEq/L} = 30 + 20 − 85 = − 35 mEq/L (Intact NH 4 + \text{NH}_4^+ NH 4 + ​ )

Final Integrated Diagnosis Mixed Disorder : Primary Respiratory Alkalosis + High Anion Gap Metabolic Acidosis Triple Disorder : Severe HAGMA (DKA) + Severe Metabolic Alkalosis (Vomiting) + Respiratory Compensation Hidden HAGMA : Sepsis-induced Lactic Acidosis unmasked by Albumin Correction Mixed Disorder : Severe NAGMA (Secretory Diarrhea) + Secondary Respiratory Acidosis (Fatigue)

Metabolic Alkalosis: Generation, Maintenance and Urine Chloride

Metabolic alkalosis needs a generating process and a maintaining process, because healthy kidneys excrete excess bicarbonate quickly.

Generation : loss of acid (vomiting, nasogastric suction, mineralocorticoid excess), an alkali load (sodium bicarbonate, citrate from massive transfusion or regional citrate anticoagulation, acetate in parenteral nutrition), contraction around a fixed bicarbonate pool (loop or thiazide diuretics), and posthypercapnic alkalosis after chronic hypercapnia is corrected too quickly on the ventilator.

Maintenance : volume and chloride depletion, hypokalemia, ongoing mineralocorticoid activity, and reduced GFR.

Urine chloride Category Causes Treatment

Low (below about 20 – 25 mEq/L 20\text{--}25\text{ mEq/L} 20 – 25 mEq/L ) Chloride-responsive Vomiting, nasogastric suction, remote diuretic use, posthypercapnia, chloride-losing diarrhea (villous adenoma) Isotonic saline and potassium chloride; reduce gastric losses (acid suppression if suction must continue)

High (above about 40 mEq/L 40\text{ mEq/L} 40 mEq/L ) with hypertension Chloride-resistant, mineralocorticoid excess Primary aldosteronism, Cushing syndrome or ectopic ACTH, licorice, renovascular disease Treat the cause; spironolactone or eplerenone; replace potassium

High without hypertension Chloride-resistant Current diuretic use, Bartter or Gitelman syndrome, severe hypokalemia, hypomagnesemia Stop the diuretic, replace potassium and magnesium

Urine sodium is misleading in active vomiting, because bicarbonaturia forces sodium into the urine despite volume depletion. Urine chloride is the better marker.

ICU-specific therapy :

Acetazolamide ( 250 – 500 mg 250\text{--}500\text{ mg} 250 – 500 mg IV) increases bicarbonate excretion in volume-overloaded patients who cannot receive saline; it worsens hypokalemia.

Reduce or stop the citrate load and correct hypokalemia and hypomagnesemia.

For severe, symptomatic alkalemia (pH above about 7.55 7.55 7.55 with arrhythmias or seizures) that does not respond, use dilute hydrochloric acid ( 0.1 – 0.2 N 0.1\text{--}0.2\text{ N} 0.1 – 0.2 N ) through a central line, or a low-bicarbonate dialysate.

On the ventilator, lower minute ventilation gradually in chronic hypercapnia to avoid posthypercapnic alkalosis.

Low or Negative Anion Gap

A low anion gap is usually an albumin effect, but it can signal toxic or hematologic disease:

Hypoalbuminemia : each 1 g/dL 1\text{ g/dL} 1 g/dL fall in albumin lowers the gap by about 2.5 mEq/L 2.5\text{ mEq/L} 2.5 mEq/L .

Cationic paraproteins : IgG multiple myeloma.

Unmeasured cations : lithium toxicity, and severe hypercalcemia or hypermagnesemia.

Bromide or iodide exposure: many analyzers read these halides as chloride ("pseudohyperchloremia"), producing a very low or negative gap.

Laboratory error, including severe hyperlipidemia.

Primary Respiratory Disorders: Common ICU Causes

Disorder Common ICU causes

Respiratory acidosis Sedatives and opioids, brainstem injury, neuromuscular weakness (Guillain-Barré syndrome, myasthenia gravis, high cervical cord injury, severe hypophosphatemia), chest-wall restriction (obesity hypoventilation, kyphoscoliosis, flail chest), obstructive disease (COPD, status asthmaticus), permissive hypercapnia, and high CO2 production (overfeeding, fever, malignant hyperthermia)

Respiratory alkalosis Hypoxemia, pulmonary embolism, pneumonia, early sepsis, salicylate toxicity, liver failure, pregnancy (progesterone), pain or anxiety, central nervous system injury, and ventilator overventilation

Salicylate toxicity typically combines a primary respiratory alkalosis with a high anion gap metabolic acidosis. Intubating such a patient without matching their high minute ventilation can cause fatal acidemia.